Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    parkinson, neurturin
Show Display Options
Rank Status Study
1 Active, not recruiting Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Biological: CERE-120: Adeno-Associated Virus Delivery of Neurturin;   Procedure: Sham Surgery
2 Completed
Has Results
Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Genetic: CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]);   Procedure: Sham Surgery
3 Completed Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Genetic: CERE-120:  AAV2-NTN

Indicates status has not been verified in more than two years